drugset / Trial / NCT00837941

A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)

NCT00837941 ↗

Phase 2 Withdrawn Merck Sharp & Dohme LLC
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine if analgesic efficacy can be detected with single dose administration in patients with chronic neuropathic pain due to painful diabetic neuropathy.

Timeline

Start
2009-04
Primary completion
2009-08
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Diphenhydramine Small molecule 25 mg —
Subject Duloxetine Small molecule 60 mg —
Subject Pregabalin Small molecule 300 mg —